ANXA1 and relapsing-remitting multiple sclerosis: A more recent study tried to shed some light on the ability of AnxA1 to influence T cell effector function in relapsing/remitting MS (RRMS); by measuring circulating expression levels of AnxA1 in RRMS patients, it was found that they are inversely correlated with disease score and progression [61].